FDA authorizes remdesivir drug as emergency treatment for COVID-19

FDA authorizes remdesivir drug as emergency treatment for COVID-19

Reuters

Published

The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.

Full Article